Exosomal miR-155 was then transferred back to neuroblastoma cells, where it silenced telomeric repeat binding factor 1 (TERF1) and resulted in increased resistance to cisplatin in chemotherapy. The gene discussed is TERF1; the disease is neuroblastoma.